Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.007.24%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.23% | 64.62% | 56.83% | 43.31% | 50.89% |
| Total Depreciation and Amortization | -55.14% | -52.82% | -40.68% | -28.86% | 30.60% |
| Total Amortization of Deferred Charges | -79.88% | -96.42% | -66.80% | -30.50% | 5.62% |
| Total Other Non-Cash Items | 127.71% | -99.92% | -99.92% | -99.90% | -136.55% |
| Change in Net Operating Assets | 42.05% | -9.81% | 9.58% | 18.93% | 30.55% |
| Cash from Operations | -182.67% | -37.86% | 351.51% | 302.93% | 200.61% |
| Capital Expenditure | 14.26% | 56.04% | 64.42% | 44.11% | -164.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 14.26% | 56.04% | 64.42% | 44.11% | -164.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 466.67% | 466.67% | -- | -- | -1,729.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.52% | 263.97% | 160.87% | 156.99% | 50.84% |